MONTREAL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Defence Therapeutics (OTCQB: DTCFF), based in adMare BioInnovations Technoparc, Montreal, focused on advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based and radiotherapeutic treatments, today announced that Amie Phinney, PhD, MBA, Strategy & Business – Director, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on December 11th. DATE: December 1 ...